fbpx
HomeInVivo Biosystems BlogNews & Announcements

News & Announcements

COVID-19’s Impact on Working Parents

While the COVID-19 pandemic has impacted us all, it isn’t a mystery that it has disproportionately impacted parents who have faced added stress, work-from-home situations, and unpredictable school / daycare closures. A recent article in Science stressed that the pandemic was particularly disruptive for parents working in a scientific field, and that these effects would be felt for years into the future – as it takes approximately three years for research to go from the concept-stage to publication. Here at InVivo Biosystems our parents are reflecting on the challenges and triumphs they have faced over the last two years.

Read More »

[Press Release] Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study

– Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue
– Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further data confirming expression pathways for genes

Read More »

InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab

Information about the COVID-19 virus (SARS-CoV-2) is constantly changing. This leaves essential business and healthcare facilities scrambling to find ways to ensure their employees, customers’ and patients’ safety. It is crucial to know if and when the virus has infiltrated a facility in order to minimize the impact that it could have. Now that non-essential …

InVivo Biosystems has partnered with Enviral Tech to help you safely return to lab Read More »

FAVOR Grant

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research

New NIH Grant awarded to InVivo Biosystems to address critical needs in precision medicine research using the model of C. elegans. The grant, titled “Functional Assessment of Variants in Organisms of Research (FAVOR) – Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping” in the amount of $350,000 is awared by the Nation Human Genome Research Institute (NHGRI).

Read More »

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics

Company Changes Operating Name to InVivo Biosystems Eugene, Ore. – March 31, 2020 – NemaMetrix is changing its operating name to InVivo Biosystems as the company expands its research platforms to accelerate deep in-vivo insights that help researchers develop and deliver therapeutic solutions for critical diseases. The company’s solutions now provide essential services to pharmaceutical, …

NemaMetrix Expands Business to Capitalize on In-vivo Solutions to Help Speed Testing for Critical Disease Therapeutics Read More »

Scroll to Top